YOU ARE HERE >  Moneycontrol Markets > Announcements PharmaceuticalsAnnouncement - Strides Pharma
Strides Pharma
BSE: 532531NSE: STARISIN: INE939A01011

11th-Aug-2020 19:21Source: BSE

Strides Pharma Science - Announcement under Regulation 30 (LODR)-Newspaper Publication

In terms of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed a copy of the newspaper advertisement published on August 11, 2020, giving notice of hearing of the petition filed before the National Company Law Tribunal, Mumbai Bench (''''Tribunal'''') for sanction of the Scheme of Amalgamation of Arrow Remedies Private Limited and Fagris Medica Private Limited and Strides Emerging Markets Limited (''Transferor Companies'') with Strides Pharma Science Limited (''Transferee Company'') and their respective Shareholders and Creditors.

The petition is fixed for hearing before the Tribunal on August 24, 2020.

The above is for your information and records.